Pasar al contenido principal

SENSIBILIDAD AL OXIGENO Y NEURODEGENERACION

PID2022-138131OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE SEVILLA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Intracellular signalling in arterial chemoreceptors during acute hypoxia and glucose deprivation: role of ATP

  • Torres López, María
  • González-Rodríguez, Patricia
  • Colinas, Olaia
  • Rho, Hee Sool
  • Torres-Torrelo, Hortensia
  • Castellano, Antonio
  • Gao, Lin
  • Ortega-Sáenz, Patricia
  • López-Barneo, José
The carotid body (CB) is the main oxygen (O2) sensing organ that mediates reflex hyperventilation and increased cardiac output in response to hypoxaemia. Acute O2 sensing is an intrinsic property of CB glomus cells, which contain special mitochondria to generate signalling molecules (NADH and H2O2) that modulate membrane K+ channels in response to lowered O2 tension (hypoxia). In parallel with these membrane-associated events, glomus cells are highly sensitive to mitochondrial electron transport chain (ETC) inhibitors. It was suggested that a decrease in oxidative production of ATP is a critical event mediating hypoxia-induced cell depolarization. Here, we show that rotenone [an inhibitor of mitochondrial complex (MC) I] activates rat and mouse glomus cells but abolishes their responsiveness to hypoxia. Rotenone does not prevent further activation of the cells by cyanide (a blocker of MCIV) or glucose deprivation. Responsiveness to glucose deprivation is enhanced in O2-insenstive glomus cells with genetic disruption of MCI. These findings suggest that acute O2 sensing requires a functional MCI but that a decrease in intracellular ATP, presumably produced by the simultaneous inhibition of MCI and MCIV, is not involved in hypoxia signalling. In support of this concept, ATP levels in single glomus cells were unaltered by hypoxia, but rapidly declined following exposure of the cells to low glucose or to inhibitors of oxidative phosphorylation. These observations indicate that a reduction in intracellular ATP does not participate in physiological acute O2 sensing. However, local decreases in ATP of glycolytic origin may contribute to low glucose signalling in glomus cells. KEY POINTS: The carotid body contains oxygen-sensitive glomus cells with specialized mitochondria that generate signalling molecules (NADH and H2O2) to inhibit membrane K+ channels in response to hypoxia. Glomus cells are highly sensitive to electron transport chain (ETC) blockers. It was suggested that a decrease in intracellular ATP is the main signal inducing K+ channel inhibition and depolarization in response to hypoxia or ETC blockade. Rotenone, an inhibitor of mitochondrial complex (MC) I, activates glomus cells but abolishes their responsiveness to hypoxia. However, rotenone does not prevent further activation of glomus cells by cyanide (an MCIV blocker) or glucose deprivation. Single-cell ATP levels were unaltered by hypoxia, but decreased rapidly following exposure of glomus cells to 0 mM glucose or inhibitors of oxidative phosphorylation. A reduction in intracellular ATP does not participate in signalling acute hypoxia. However, it may contribute to hypoglycaemia signalling in glomus cells., This research was supported by Spanish Ministries of Science and Innovation and Health (Grants PID2019-106410RB-I00, PID2019-110817R, PID2022-138131OB-I00 and PID2023-146862OB-100 funded by MCIN/AEI/10.13039/501100011033 to J.L.-B., L.G. and P.O.-S) and the European Research Council (ERC Advanced Grant PRJ201502629)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The carotid body oxygen sensor

  • Gao, Lin
  • Moreno-Domínguez, Alejandro
  • Ortega-Sáenz, Patricia
  • López-Barneo, José
Carotid body (CB) chemoreceptor glomus cells sense hypoxia through the inhibition of plasmalemmal K+ channels, which leads to the opening of Ca2+ channels, Ca2+ influx, and neurotransmitter release. The mechanism of O2 sensing and the regulation of membrane ion channels by O2 have remained undefined and a subject of debate. Here, we summarize the molecular pathway that underlies acute O2 sensing in the CB. This process does not rely on a single-molecule O2 sensor expressed in glomus cells but rather on HIF2α-dependent genetically specialized mitochondria that can detect changes in O2 tension, within physiological ranges, and generate biochemical signals that regulate membrane ion channels. The acute O2-sensing pathway in glomus cells could provide new targets for respiratory and cardiovascular pharmacology., This research was supported by the Spanish Ministries of Science and Innovation and Health (Grants PID2022-138131OB-I00, and PID2023-146862OB-100 funded by MCIN/AEI/10.13039/501100011033 to J.L.-B., L.G. A.M.-D. and P.O.-S) and the European Research Council (ERC Advanced Grant PRJ201502629)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Genetic map of the carotid body stem cell niche with focus on the O2-sensing chemoreceptor cell lineage

  • Santamaría-Santiago, Ana
  • Sobrino, Verónica
  • Luna Ramírez, Luis
  • López-Barneo, José
  • Pardal Redondo, Ricardo
[Data availability] The single-cell transcriptomic data have been deposited in the Gene Expression Omnibus (GEO) under the accession number GSE295692. All additional data supporting the conclusions of this study are included in the main manuscript and Supplementary Materials., Adaptive homeostatic responses to oxygen (O2) deficiency (hypoxia) are essential for survival. The prototypical acute O2-sensing organ is the carotid body (CB), a neural crest-derived tissue with chemoreceptor glomus cells that express hypoxia-inhibited K+ channels. This, in turn, leads to neurotransmitter release and the activation of nerve fibers terminating in the brainstem, evoking hyperventilation. The adult CB contains a population of multipotent stem cells capable of proliferating and differentiating into new chemoreceptor cells, supporting its growth during acclimatization to chronic hypoxia. The responsiveness of glomus cells to hypoxia relies on the constitutive expression of HIF2α and a set of HIF2α-dependent genes, which define a mitochondria-to-membrane signaling pathway for acute O2 sensing. The genetic profiles of the various cell types within the CB, and how they change in response to sustained hypoxia, remain unknown. Here, we present a complete transcriptomic map of the CB, with an emphasis on the characterization of genetic profiles of the acute O2-sensing neuronal cell lineage (multipotent progenitors, neuroblasts, and mature glomus cells). Acclimatization to chronic hypoxia involves the rapid conversion of neuroblasts into mature O2-sensitive chemoreceptor cells and enhancement of the glomus cell O2-sensing and neurosecretory genetic profile., This work was supported by grants from the Spanish Ministry of Science and Innovation (PID-2022-142424OB-I00 and PID2022-138131OB-I00)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Phosphodiesterase Inhibition Increases Striatal GDNF and Protects Against Preclinical Parkinsonism

  • d’Anglemont de Tassigny, Xavier
  • Jiménez-Medina, Alejandro
  • López-López, Ivette
  • López-Barneo, José
Glial cell line-derived neurotrophic factor (GDNF) has been investigated as a therapeutic agent for Parkinson's disease (PD), albeit with variable clinical outcomes. In the brain, GDNF is predominantly produced by striatal interneurons. Given that Gdnf gene expression is regulated by cyclic adenosine monophosphate (cAMP)-dependent signaling, a compelling strategy for PD treatment is the pharmacological elevation of intracellular cAMP. This approach aims to enhance endogenous GDNF, offering potential neuroprotective benefits. In this study, we show that selective inhibition of phosphodiesterases (PDEs) subtypes, therefore enhancing intracellular cAMP levels, increases Gdnf mRNA expression in striatal slices ex vivo; however, achieving this effect in vivo proved more challenging. To address this, we evaluated Ibudilast, a clinically approved non-selective PDE inhibitor. Ibudilast robustly upregulated striatal Gdnf expression both ex vivo and in vivo following systemic administration. In a chronic MPTP mouse model of PD, Ibudilast treatment conferred significant neuroprotection, as evidenced by preservation of tyrosine hydroxylase-positive (TH+) neurons in the substantia nigra, attenuation of TH+ fiber loss in the striatum, and mitigation of striatal dopamine depletion. Given its established clinical use and favorable safety profile, these findings support further investigation of Ibudilast as a potential disease-modifying therapy in PD., This study was supported by Fundación Tatiana Pérez de Guzmán el Bueno Foundation, Spanish Ministry of Science, Innovation and Universities (PID2022-138131OB-I00, PREP2022-000587), and Andalusian Plan for Research, Development and Innovation (P18-RT-3100)., We appreciate support from the “Tatiana Pérez de Guzman el Bueno Foundation,” the Andalusian Plan for Research, Development and Innovation (PAIDI2020, project P18-RT-3100), and the Spanish Ministry of Science, Innovation and Universities (projects PID2022-138131OB-I00, PREP2022-000587, and PID2022-136685OA-I00). We are grateful to the mass spectrometry core facility (Citius) and Dr. Martiniano Santiago Pavon (Dept. of Pharmacy, University of Seville) for consultation and special reagent supply., Peer reviewed